Ledyard National Bank’s Trinity Biotech TRIB Stock Holding History

Ledyard National Bank’s Portfolio TRIB Stock Details TRIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-35	Closed	-$3K	–	725
2014 Q4	$3K	Hold	35	–	–	﹤0.01%	681
2014 Q3	$3K	Hold	35	–	–	﹤0.01%	659
2014 Q2	$4K	Hold	35	–	–	﹤0.01%	642
2014 Q1	$4K	Hold	35	–	–	﹤0.01%	626
2013 Q4	$4K	Buy	+35	New	+$4.2K	﹤0.01%	633

Other funds holding TRIB

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

CCMLC

Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

AAM

ACK Asset Management Greenwich, Connecticut $801M AUM 60.42% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

TAM

THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return

CAM

Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

RCMC

RK Capital Management (Colorado) Denver, Colorado $324K AUM 47.52% 1-Year Est. Return

Ledyard National Bank's TRIB Position: Q1 2015 in Review

Ledyard National Bank sold out of Trinity Biotech (TRIB) in Q1 2015, closing a stake of 35 shares — an estimated $3K sold.

Ledyard National Bank first reported a position in TRIB in Q4 2013 and held it in 5 quarters. The position peaked at $4K in Q2 2014. 89 funds tracked by Wall St. Rank hold TRIB as of Q1 2015.

Ledyard National Bank reported no remaining Trinity Biotech position as of Q1 2015 after selling out during the quarter.
Ledyard National Bank sold 35 Trinity Biotech shares in Q1 2015, an estimated $3K.
Ledyard National Bank first reported a position in Trinity Biotech in Q4 2013 and held it in 5 quarters.
Ledyard National Bank's Trinity Biotech position peaked at $4K in Q2 2014.
89 funds tracked by Wall St. Rank held Trinity Biotech as of Q1 2015.

Based on Ledyard National Bank's 13F filing for Q1 2015, filed 15 Apr 2015.